A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...

There have been few studies that have been able to take a comprehensive look at how these medications, which include Ozempic, ...

ORLANDO, Fla. (Ivanhoe Newswire)--- Research shows more than half of pregnant women gain too much weight — and 70% eat excessive amounts of sugar, sodium, and saturated fats. Now, a new study ...

Calorie labels on menus and food packaging lead to people eating one less crisp than usual - but the effects can still be "potentially meaningful", according to a new review. Evidence from 25 ...

Wegovy and Zepbound tipped to fuel $20B boom in heart ... s drug lost an average of 20.2% of their weight after 72 weeks, while those taking Wegovy lost 13.7% of their weight in the same span ...

From science-backed supplements to insurance-covered nutrition therapy, here's your complete guide to effective weight loss ...

Specifically, the risk of SCD increased by 14 percent for those eating one-quarter or more servings of processed meat daily compared to the minimal-consumption group, and by 16 percent for those ...

Best of luck, and do keep in touch. … When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens ...

Management attributed this lowered guidance to the slowed sales growth of its tirzepatide products in the fourth quarter — diabetes drug Mounjaro added $3.5 billion, while obesity drug Zepbound ...

Shares of NVO declined 4% on Tuesday, while VKTX was down 12.7% after Lilly announced disappointing preliminary fourth-quarter sales of Mounjaro and Zepbound. AMGN’s stock declined slightly more ...